Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02145728
Other study ID # MGH-14-UL
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2014
Est. completion date December 2018

Study information

Verified date December 2018
Source University of Limerick
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate whether individual cognitive functional therapy (CFT), when compared to group exercise classes is effective in reducing pain and disability in patients with non-specific chronic low back pain.


Description:

A multi-centre randomised study with 6 month, 12 month and 36 month follow up will be used. Patient with non- specific chronic low back pain will be assessed for eligibility. The patients fitting the inclusion criteria will be randomised to receive either the individual CFT or the group classes consisting of education and exercise. Participants' pain, disability, socio-economic status, beliefs, fear, catastrophizing, self-efficacy, general health, stress levels, as well as number and cost of treatments will be evaluated using a range of outcome measures at the start and on completion of the treatment. Patients will receive another copy of the questionnaires in the post at 6 month, 12 months and 36 months after treatment to reassess clinical outcomes. If a participant does not respond to follow-up, they will be telephoned to ask if they wish to complete the questionnaires.


Recruitment information / eligibility

Status Completed
Enrollment 208
Est. completion date December 2018
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Aged between 18 and 75

- Chronic low back pain greater than 6 months duration

- Score greater than 14% for disability on Oswestry Disability Index (ODI)

- Independently mobile (with or without aids), to be capable of participating in a rehabilitation programme

Exclusion Criteria:

- Primary pain area is not the lumbar spine (from T12-buttocks)

- Leg pain as the primary problem (nerve root compression or disc prolapse with true radicular pain/radiculopathy, lateral recess/central or spinal stenosis with primary leg pain)

- <6 months post lumbar spine or lower limb or abdominal surgery

- Pain relieving procedures such as injection based therapy (e.g epidurals) and day case procedures (e.g rhizotomy) in the last 3 months

- Pregnancy

- Rheumatologic/inflammatory disease (e.g. rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis, lupus, scheuermann's disease)

- Progressive neurological disease (e.g. multiple sclerosis (MS), parkinson's disease (PD), motor neuron disease (MND)

- Unstable cardiac conditions

- Red flag disorders like malignancy/cancer, acute traumas like fracture (<6 months ago) or infection, spinal cord compression/cauda equina

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Individual Cognitive Functional Therapy
Cognitive functional therapy (CFT) is a novel, patient centred behavioural intervention which addresses multiple dimensions in non-specific chronic low back pain (NSCLBP). It combines a functional behavioural approach of normalising provocative postures and movements while discouraging pain behaviours, with cognitive restructuring of the NSCLBP problem.
Group Exercise Classes
Each class involves a combination of education, exercise and relaxation/mindfulness. The education topics include pain and the nervous system, posture and ergonomics, exercise and relaxation and sleep. The exercise component includes 10 stations of a combination of aerobic, strength and flexibility exercises. These will be walking/jogging on the spot, mini-squats, sit to stands, wall push ups, bridging, step-ups and a combination of leg and low back stretches. The relaxation/mindfulness component will take place at the end of each class and will involve breathing and relaxation of the body.

Locations

Country Name City State
Ireland Ballina Primary Care Centre Mayo Connacht
Ireland Claremorris Primary Care Centre Mayo Connacht
Ireland Mayo General Hospital Mayo Connacht

Sponsors (5)

Lead Sponsor Collaborator
University of Limerick Curtin University, Health Service Executive, Ireland, KU Leuven, Mayo General Hospital, Ireland

Country where clinical trial is conducted

Ireland, 

References & Publications (2)

O'Sullivan P. It's time for change with the management of non-specific chronic low back pain. Br J Sports Med. 2012 Mar;46(4):224-7. doi: 10.1136/bjsm.2010.081638. Epub 2011 Aug 4. — View Citation

Vibe Fersum K, O'Sullivan P, Skouen JS, Smith A, Kvåle A. Efficacy of classification-based cognitive functional therapy in patients with non-specific chronic low back pain: a randomized controlled trial. Eur J Pain. 2013 Jul;17(6):916-28. doi: 10.1002/j.1 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Oswestry Disability Index (ODI) Used to assess change in disability levels over the course of the trial and follow-up Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Secondary Numerical rating scale (NRS) Measures pain intensity Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Secondary Socio-economic Conditions Index Measures socio-economic status Baseline
Secondary Back Pain Beliefs Questionnaire Assess a person's beliefs about their back pain Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Secondary Physical activity subscale of the Fear-Avoidance Beliefs Questionnaire (FABQ) Assesses a person's level of fear-avoidance beliefs regarding physical activities. Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Secondary The catastrophising subscale of the Coping Strategies Questionnaire (CSQ) Assesses level of pain catastrophizing. Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Secondary Pain Self- Efficacy Questionnaire (PSEQ) Assesses level of pain self-efficacy Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Secondary Subjective Health Complaints Inventory (SHC) Assess level of subjective health complaints Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Secondary Nordic Musculoskeletal Screening Questionnaire Assesses areas of bodily pain Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Secondary Stress subscale of the Depression, Anxiety and Stress scale (DASS 21) Assesses patient's stress levels. Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Secondary Patient Satisfaction Questionnaire Assesses patient satisfaction At 8-14 weeks
Secondary Short-Form Orebro Musculoskeletal Screening Questionnaire (OMSQ) Stratifies patients into low, medium or high risk of delayed pain recovery and chronicity. Measured at baseline
Secondary Medication usage To assess changes in levels of medication used. Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months
Secondary Economic evaluation Assesses direct and indirect costs of both treatment arms to see which is more cost-effective. 6, 12 and 36 months
Secondary Level of co-interventions Assesses the number/type of healthcare services availed of throughout the intervention period. Baseline, post-intervention (at 8-14 weeks), 6, 12 and 36 months
See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3